Edition:
United States

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

3.33USD
15 Dec 2017
Change (% chg)

$-0.05 (-1.48%)
Prev Close
$3.38
Open
$3.34
Day's High
$3.40
Day's Low
$3.26
Volume
3,252
Avg. Vol
9,445
52-wk High
$5.55
52-wk Low
$1.22

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.30 -0.112
Jun '17 0.21 -0.500
Mar '17 0.57 -0.151
FY 2016 Dec '16 0.99 -0.112
Sep '16 1.14 0.104
Jun '16 0.58 -0.173
Mar '16 0.81 -0.061
FY 2015 Dec '15 1.27 -0.132
Sep '15 0.50 -0.307
Jun '15 0.33 -1.117
Mar '15 0.61 -1.138
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. 9.46 280.37 45.35
P/E Low - Last 5 Yrs. 9.46 93.75 24.23
Beta -0.39 0.82 0.91
Price to Sales (TTM) 18.00 122.78 5.95
Price to Book (MRQ) 11.07 23.45 5.68
Price to Tangible Book (MRQ) 11.07 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions 3.95 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -73.99 -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago -45.56 29.98 5.62
Sales - 5 Yr. Growth Rate -16.73 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago -207.87 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago -234.86 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate -59.84 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.55
Current Ratio (MRQ) 4.76 5.62 3.56
LT Debt to Equity (MRQ) 0.00 16.22 13.38
Total Debt to Equity (MRQ) 0.00 18.71 19.38
Interest Coverage (TTM) -- -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -299.65 -- --
EBITD - 5 Yr. Avg -377.16 -215.66 15.63
Operating Margin (TTM) -300.94 -642.63 6.56
Operating Margin - 5 Yr. Avg. -320.58 -232.87 11.00
Pre-Tax Margin (TTM) -474.84 -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -264.44 -233.04 11.41
Net Profit Margin (TTM) -474.84 -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -264.44 -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 137,845 22,314,532 851,801,741
Net Income/Employee (TTM) -654,541 -1,997,855 99,542,701
Receivable Turnover (TTM) 2.22 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) 0.15 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -70.38 -9.39 11.31
Return on Assets - 5 Yr. Avg. -57.32 0.28 12.28
Return on Investment (TTM) -159.96 -11.76 14.43
Return on Investment - 5 Yr. Avg. -262.99 3.42 16.07
Return on Equity (TTM) -159.15 -36.72 16.01
Return on Equity - 5 Yr. Avg. -367.36 5.75 17.27
  1 Year 3 Year 5 Year
Sales % 29.92 -25.44 -16.73
EPS (TTM) % 86.48 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cleveland Biolabs Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.94%
# of Holders: 23
Total Shares Held: 444,939
3 Mo. Net Change: -78,384
# New Positions: 2
# Closed Positions: 3
# Increased Positions: 6
# Reduced Positions: 8
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.